Orange Book product · Brand (NDA)
EFFEXOR XR
VENLAFAXINE HYDROCHLORIDE
At a glance
Oct 20, 1997
Approved
Brand (NDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 20, 1997
29 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
VENLAFAXINE HYDROCHLORIDE
Strength
EQ 150MG BASE
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
TE code
AB
Application
NDA 020699
Product number
004
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2008VENLAFAXINE HYDROCHLORIDEBrand (NDA)
NDA 022104 · OSMOTICA PHARM US
- 1993EFFEXORBrand (NDA)
NDA 020151 · WYETH PHARMS INC
- 2025VENLAFAXINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217841 · ABON PHARMS LLC
- 2025VENLAFAXINE HYDROCHLORIDEGeneric (ANDA)
ANDA 218180 · TORRENT
- 2024VENLAFAXINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217767 · ALEMBIC
- 2023VENLAFAXINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217390 · GRANULES
- 2023VENLAFAXINE HYDROCHLORIDEGeneric (ANDA)
ANDA 214691 · AJANTA PHARMA LTD
- 2023VENLAFAXINE HYDROCHLORIDEGeneric (ANDA)
ANDA 200430 · NOSTRUM PHARMS LLC
- 2022VENLAFAXINE HYDROCHLORIDEGeneric (ANDA)
ANDA 216044 · UNIQUE
- 2022VENLAFAXINE HYDROCHLORIDEGeneric (ANDA)
ANDA 215622 · ZYDUS PHARMS
- 2022VENLAFAXINE HYDROCHLORIDEGeneric (ANDA)
ANDA 214423 · PHARMADAX
- 2021VENLAFAXINE HYDROCHLORIDEGeneric (ANDA)
ANDA 214654 · YICHANG HUMANWELL
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
